► Draft guideline on the pharmaceutical quality of inhalation and nasal medicinal products
► Draft guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD)
More details and source documents available on EMA website (see links section).
